Available from: Nwobodo N
Understanding Semaglutide Semaglutide is a medication commonly used in the treatment of type 2 diabetes and obesity, with significant effects on weight loss and glycemic control
Empagliflozin undergoes extensive hepatic glucuronidation via UGT2B7, UGT1A3, UGT1A8, and UGT1A9
Ozempic is a GLP-1 medication that is FDA approved and helps to suppress hunger and support weight loss in a slow, controlled manner under medical supervision
In people without diabetes , hypoglycaemia is relatively uncommon but can occur due to: Prolonged fasting or inadequate carbohydrate intake Excessive alcohol consumption , particularly without food Certain medications , including specific antibiotics (e.g., fluoroquinolones), quinine, and pentamidine (though these are rare causes) Hormonal deficiencies affecting cortisol or growth hormone Rare conditions such as insulinomas (insulin-producing tumours) or reactive hypoglycaemia Critical illness or organ failure affecting the liver or kidneys For individuals with diabetes , hypoglycaemia is more frequent and typically results from: Insulin or sulphonylurea medications (such as gliclazide or glimepiride) Missed or delayed meals after taking glucose-lowering medication Increased physical activity without adjusting medication or food intake Alcohol consumption which impairs the liver's glucose production Medication errors or dose miscalculations Symptoms of hypoglycaemia include trembling, sweating, anxiety, hunger, palpitations, confusion, and in severe cases, loss of consciousness or seizures
Ja, BPC 157 trgt zur Zellregeneration bei und untersttzt so die Wiederherstellung und langfristige Gesundheit von Gewebe
